Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3125 of 3546 entries
View as:

Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT00896064 Org: User:
Start: 05/18/09 End: 08/05/09 Due: 08/05/10

A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).

Phase: N/A Priority: Normal
NCT ID: NCT00103454 Org: User:
Start: 01/31/05 End: 05/31/05 Due: 05/31/06

Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation

Phase: N/A Priority: Normal
NCT ID: NCT00621894 Org: User:
Start: 03/15/08 End: 05/15/09 Due: 05/15/10

Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01641042 Org: User:
Start: 09/10/12 End: 03/03/15 Due: 03/03/16

A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00843492 Org: User:
Start: 12/31/08 End: 06/30/10 Due: 06/30/11

A 35 Day Study to Investigate the Effects of GSK1521498 on Bodyweight in Obese Subjects With Over-Eating Behaviours.

Phase: N/A Priority: Normal
NCT ID: NCT01195792 Org: User:
Start: 09/30/10 End: 05/31/11 Due: 05/31/12

Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs

Phase: N/A Priority: Normal
NCT ID: NCT00541970 Org: User:
Start: 10/17/07 End: 03/18/13 Due: 03/18/14

Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism

Phase: N/A Priority: Normal
NCT ID: NCT01004939 Org: User:
Start: 03/31/10 End: 07/31/10 Due: 07/31/11

Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00387764 Org: User:
Start: 09/30/06 End: 10/31/12 Due: 10/31/13

To Examine The Effects Of Lapatinib On Orally And Intravenously Administered Midazolam In Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00258050 Org: User:
Start: 11/21/05 End: 02/08/07 Due: 02/08/08

Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02504671 Org: User:
Start: 07/23/15 End: 12/29/17 Due: 12/29/18

Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules

Phase: N/A Priority: Normal
NCT ID: NCT00316147 Org: User:
Start: 12/31/05 End: 08/31/06 Due: 08/31/07

SD Cystic Fibrosis Study

Phase: N/A Priority: Normal
NCT ID: NCT00605761 Org: User:
Start: 02/29/08 End: 12/31/08 Due: 12/31/09

GSK573719 IV Enabling Study

Phase: N/A Priority: Normal
NCT ID: NCT01110018 Org: User:
Start: 04/28/10 End: 06/09/10 Due: 06/09/11

Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00103727 Org: User:
Start: 12/31/04 End: 10/31/05 Due: 10/31/06

A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040

Phase: N/A Priority: Normal
NCT ID: NCT00562848 Org: User:
Start: 09/10/07 End: 06/27/08 Due: 06/27/09

Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01847404 Org: User:
Start: 05/14/13 End: 06/28/13 Due: 06/28/14

A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab

Phase: N/A Priority: Normal
NCT ID: NCT01495000 Org: User:
Start: 01/31/12 End: 02/28/13 Due: 02/28/14

Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT01332487 Org: User:
Start: 08/31/10 End: 08/31/10 Due: 08/31/11

GW824575 First Time in Human

Phase: N/A Priority: Normal
NCT ID: NCT01551771 Org: User:
Start: 02/01/12 End: 04/12/12 Due: 04/12/13

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT04062669 Org: User:
Start: 08/13/19 End: 07/01/22 Due: 07/01/23

Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00235755 Org: User:
Start: 12/31/05 End: 04/30/08 Due: 04/30/09

A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT06354257 Org: User:
Start: 04/05/24 End: 07/01/24 Due: 07/01/25

Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in Children

Phase: N/A Priority: Normal
NCT ID: NCT00696423 Org: User:
Start: 06/07/08 End: 07/26/08 Due: 07/26/09

Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03055195 Org: User:
Start: 03/21/17 End: 12/06/17 Due: 12/06/18